Longitudinal screening of HLA‐risk and HLA‐nonrisk children for celiac disease to age 15 years: CiPiS study
Journal of Pediatric Gastroenterology and Nutrition · 2024
DOI: 10.1002/jpn3.12181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Michaela Boström und 3 weiteren Autor:innen. Beteiligte Einrichtung: Celiac Disease and Diabetes Unit, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Celiac Disease, Transglutaminases, Autoantibodies, Immunoglobulin A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: None.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
Autoantibodies against tissue transglutaminase (tTG) are serological markers of celiac disease. The aim was to study the applicability of human leukocyte antigen (HLA)‐genotyping and tTG autoantibodies in the screening of celiac disease in a longitudinal birth cohort followed to age 15 years.
Methods
Included were 13,860 HLA‐DQ‐genotyped children at birth and previously invited to a screening at age 3 and 9 years, respectively. HLA‐DQB1*02 and/or DQB1*03:02 (HLA‐risk) children were compared with non‐HLA‐DQB1*02 and non‐DQB1*03:02 (HLA‐nonrisk) children. The present study reinvited 12,948/13,860 (93.4%) children at age 15 years of whom 1056/2374 (44.5%) participated in screening at both age 3 and 9 years. Both immunoglobulin A (IgA) and G (IgG) autoantibodies against tTG were analyzed separately in radiobinding assays. Persistently tTG autoantibody‐positive children were examined with intestinal biopsy to confirm the diagnosis of celiac disease.
Results
At age 3 years, celiac disease was diagnosed in 56/1635 (3.4%) HLA‐risk children compared with 0/1824 HLA‐nonrisk children ( p < 0.001). By age 9 years, celiac disease was diagnosed in 72/1910 (3.8%) HLA‐risk children compared with 0/2167 HLA‐nonrisk children ( p < 0.001). Screening at age 15 years detected 14/1071 (1.3%) HLA‐risk children positive for IgA‐tTG and/or IgG‐tTG of whom 12/1071 (1.1%) remained persistently positive. Among those, 10/1071 (0.9%, 95% confidence interval: 0.4%–1.7%) HLA‐risk children were diagnosed with celiac disease compared with 0/1303 HLA‐nonrisk children ( p < 0.001) and 5/491 (1.0%) were negative in screenings at both 3 and 9 years of age.
Conclusions
Screening for celiac disease needs to be performed at multiple timepoints to detect all cases but can be restricted to children at HLA‐risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Celiac Disease and Diabetes Unit, Lund University, Malmö, Sweden.
Förderung
- None
Zitieren
APA
Boström, M., Brundin, C., Björck, S., & Agardh, D. (2024). Longitudinal screening of HLA‐risk and HLA‐nonrisk children for celiac disease to age 15 years: CiPiS study. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12181
Vancouver
Boström M, Brundin C, Björck S, Agardh D. Longitudinal screening of HLA‐risk and HLA‐nonrisk children for celiac disease to age 15 years: CiPiS study. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12181
BibTeX
@article{Bostrm2024,
author = {Boström, Michaela and Brundin, Charlotte and Björck, Sara and Agardh, Daniel},
title = {Longitudinal screening of HLA‐risk and HLA‐nonrisk children for celiac disease to age 15 years: CiPiS study},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2024},
doi = {10.1002/jpn3.12181}
}
EUVIMED